Pyoderma gangrenosum in a patient with autoimmune haemolytic anaemia and complement deficiency

British Journal of Dermatology

Volumn 143, Issue 1, 2000, Pages 154-156

  Coors, E A ^a   Von Den Driesch, P ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Autoimmune haemolytic anaemia; Complement deficiency; Pyoderma gangrenosum

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; COMPLEMENT DEFICIENCY; DEBRIDEMENT; DISEASE ASSOCIATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SKIN GRAFT;

ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; COMPLEMENT C2; COMPLEMENT C4; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; PREDNISONE; PYODERMA GANGRENOSUM;

EID: 0033914635     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03606.x     Document Type: Article

References (18)

1. Brunsting LA, Goeckermann WH, O'Leary PA. Pyoderma (cchthyma) gangrcnosum-clinical and experimental observations in five cases occurring in adults. Arch Dermatol 1930; 22: 655-80.
2. von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. BrJ Dermatol 1997: 137: 1000-5.
3. Gallen JP. Pyoderma gangrenosum. Lancet 1998: 351: 581-5.
4. Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996: 34: 395-409.
5. Prystowsky JH, Kahn SN, Lazarus GS. Present status of pyoderma gangrenosum. Review of 21 cases. Arch Dermatol 1989: 125: 57-64.
6. Hüner A, Hornstein OP, von den Driesch P. Pyoderma gangraenosum-Klinik, assoziierte Erkrankungen und Therapiemöglichkeiten. Dtsch Arztebl 1995: 92: A1998-2002.
7. Powell FC, Schroeter AL, Perry HO, Su WP. Direct immunofluorescence in pyoderma gangrenosum. Er J Dermatol 1983: 108: 287-93.
8. Su WP. Schroeter AL. Perry HO, Powell FC. Histopathologic and immunopathologic study of pyoderma gangrenosum. J Cutati Pathol 1986: 13: 323-30.
9. Chow RK, Ho VC. Treatment of pyoderma gangrenosum. J Am Acad Dermatol 1996; 34: 1047-60.
10. Friduss SR, Sadoff VI. Hern AE, Fivenson DP. Fatal pyoderma gangrenosum in association with C7 deficiency. / Am Acad Dermatol 1992; 27: 356-9.
11. Assady S, Bergman R, Finkelstein R, Edoute Y. Pyoderma gangrenosum associated with myelofibrosis. (Letter.) Er J Dermatol 1998; 139: 163-4.
12. Sgarabotto D, Vianello F. Valeri P et al. Pyoderma gangrenosum associated with idiopathic myelofibrosis. Case history. Haematol Budap 1993; 25: 249-52.
13. Goulden V, Bond L, Highet AS. Pyoderma gangrenosum associated with paroxysmal nocturnal haemoglobinuria. Clin ExpDermatol 1994; 19: 271-3.
14. Serrano J. Rojas R, Sanchez J et al Pyoderma gangrenosum associated with Fanconi's anemia. (Letter.) Dermatology 1998; 196: 370-1.
15. Wong CK, Pun KK. Lum CC et al Pyoderma gangrenosum associated with erythroid hypoplasia. Postgrad Med J 1990; 66: 312-13.
16. Beurey J, Canton P, Weber M et al Cervical pyoderma gangrenosum: treatment by plasma exchanges. Ann Dennatol Venereal 1982; 109: 455-9.
17. Hartmann D, Fremeaux-Bacchi V, Weiss L et al Combined heterozygous deficiency of the classical complement pathway proteins C2 and C4. / Ctoi Immunol 1997; 17: 176-84.
18. Ruddy S. Rheumatic diseases and inherited complement deficiencies. Bull Rheum Dis 1996: 45: 6-8.